Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06539377 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma

Study acronym: LIVINCA
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is supposed to make liver transplantation available for treatment in well selected patients suffering from non-resectable intrahepatic cholangiocarcinoma. Donor organ shortage is currently the main problem for organ transplantation world-wide. Thus, the particular indication "non-resectable intrahepatic cholangiocarcinoma" is currently excluded in terms of transplantation. Given those circumstances, transplantation via living donation might be the best option. This procedure does not reduce the deceased donor organ supply because living donation is the primary treatment option in these patients (not subsidiary).
Trial Details
NCT Number NCT06539377
Lead Sponsor Jena University Hospital
Conditions
(from sponsor)		 Living Donor Liver Transplantation, Liver Transplantation, Neoadjuvant Therapy
Related terms Cholangiocarcinoma
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov